文献速递瓣膜外科

中危患者TAVI与外科换瓣观察性研究的方法学缺陷

The flaws in the detail of an observational study on transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate-risks patients.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

针对PARTNER组比较SAPIEN 3经导管主动脉瓣植入(TAVI)与外科主动脉瓣置换(SAVR)在中危患者中的观察性研究,本文指出其倾向性评分分析存在模型设定错误、未校正关键协变量、使用五分位而非匹配、推断未校正Kaplan-Meier曲线等方法学问题,认为这些缺陷使直接比较无效,不能支持TAVI优于手术的结论。

要点

  • 倾向性评分未校正左室射血分数、中重度二尖瓣反流及合并手术等关键协变量。
  • 使用倾向性评分五分位而非匹配,且推断基于未校正的Kaplan-Meier曲线。
  • 方法学缺陷使TAVI与SAVR的直接比较无效,不能支持TAVI优效结论。

核心结论

  • 该观察性研究的方法学缺陷使TAVI与SAVR的直接比较无效,不能支持SAPIEN 3在中危患者中优于手术的结论。

研究设计与样本

  • 本文为对PARTNER组已发表的比较SAPIEN 3 TAVI与SAVR在中危患者中疗效的观察性研究的方法学评论。

主要发现

  • 倾向性评分分析存在明显模型设定错误,未校正左室射血分数、中重度二尖瓣反流及合并手术等差异最显著的协变量。
  • 研究使用倾向性评分五分位而非匹配,且推断基于未校正的Kaplan-Meier曲线。
  • 存在模型拟合不佳的证据,且缺乏瓣膜相关死亡数据。

临床怎么用

  • 临床解读该观察性研究时需谨慎,不应据此认为TAVI在中危患者中可替代手术。

局限性

  • 本文为方法学评论,未提供新的原始数据或样本量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The PARTNER group recently published a comparison between the latest generation SAPIEN 3 transcatheter aortic valve implantation (TAVI) system (Edwards Lifesciences, Irvine, CA, USA) and surgical aortic valve replacement (SAVR) in intermediate-risk patients, apparently demonstrating superiority of the TAVI and suggesting that TAVI might be the preferred treatment method in this risk class of patients. Nonetheless, assessment of the non-randomized methodology used in this comparison reveals challenges that should be addressed in order to elucidate the validity of the results. The study by Thourani and colleagues showed several major methodological concerns: suboptimal methods in propensity score analysis with evident misspecification of the propensity scores (PS; no adjustment for the most significantly different covariates: left ventricular ejection fraction, moderate-severe mitral regurgitation and associated procedures); use of PS quintiles rather than matching; inference on not-adjusted Kaplan-Meier curves, although the authors correctly claimed for the need of balancing score adjusting for confounding factors in order to have unbiased estimates of the treatment effect; evidence of poor fit; lack of data on valve-related death.These methodological flaws invalidate direct comparison between treatments and cannot support authors' conclusions that TAVI with SAPIEN 3 in intermediate-risk patients is superior to surgery and might be the preferred treatment alternative to surgery.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Barili F, Freemantle N, Folliguet T, et al. The flaws in the detail of an observational study on transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate-risks patients. Eur J Cardiothorac Surg. 2017. PMID: 28531333. doi:10.1093/ejcts/ezx058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。